Despite positive new research findings, use of antiviral meds against the flu remains controversial
A new study lends support to the Centers for Disease Control and Prevention's (CDC) move in January to recommend early, aggressive treatment with antiviral drugs in patients who present with symptoms of the flu. The new research, conducted by investigators at the University of Michigan, the London School of Hygiene and Tropical Medicine, and the University of Alabama, and published online in The Lancet, found that oseltamivir, which is marketed as Tamiflu, can shorten the duration of symptoms by about a day, and reduces by 44% the development of respiratory infections.1
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.